Zobrazeno 1 - 5
of 5
pro vyhledávání: '"O. S. Kuz'mina"'
Autor:
P. O. Bogomolov, M. V. Matsievich, K. Yu. Kokina, O. S. Kuz'mina, S. V. Koblov, N. V. Voronkova, M. Yu. Petrachenkova, A. O. Bueverov, O. V. Uvarova, E. V. Fedosova, M. N. Trofimova, V. D. Beznosenko, E. N. Kudryavtseva, E. M. Kondratenko, L. S. Gorbunova, I. M. Shilkina, T. N. Sheshukova, I. N. Kovalev, G. V. Sadovskaya, N. V. Kosheleva, Yu. Yu. Gumerova, I. N. Azarova, S. V. Ivannikova, E. N. Cherenkova, N. A. Gorshilina, M. L. Samsonyan, V. A. Sinitsyna, S. I. Kiyan, O. A. Kudrya, G. G. Chernyavskaya
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 40, Pp 48-57 (2016)
Background: The beginning of a new era of direct acting antivirals sets up its own rules, that is, to achieve the highest efficacy with the shortest duration of treatment. It is assumed that the use of the first generation of direct acting antivirals
Externí odkaz:
https://doaj.org/article/67891c4eb334417287708e9272320e3e
Autor:
P. O. Bogomolov, M. V. Matsievich, K. Yu. Kokina, N. V. Voronkova, O. S. Kuz'mina, A. O. Bueverov
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 40, Pp 126-131 (2016)
Treatment of chronic hepatitis B during pregnancy is an extremely complicated issue. Despite implementation of immune prophylaxis, a significant proportion of babies born by mothers with high viral load are infected by hepatitis B virus. Cumulative d
Externí odkaz:
https://doaj.org/article/2b95ad5aabfb490ab3c40fa215a56be5
Autor:
D. V. Dubodelov, Kuzin Sn, E. N Kudryavtseva, O. S. Kuz'mina, I. M. Korabelnikova, Lavrov Vf, V. M. Matsievich, Semenenko Ta, Natalia Voronkova, P. O. Bogomolov
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 15, Iss 2, Pp 11-18 (2016)
The structure of HCV genotypes/subtypes and dynamics of its changes in a cohort of adult patients with chronic hepatitis C (n = 17229) was studied during 2008-2015 in the Moscow region. The prevalence of subtypes 1b and 3A HCV, whose relative density
Autor:
O. S. Kuz'mina, Natalia Voronkova, K. Yu. Kokina, Alexey O. Bueverov, Pavel O. Bogomolov, M. V. Matsievich
Publikováno v:
Almanac of Clinical Medicine. :126-131
Autor:
T. N. Sheshukova, O. V. Uvarova, S. V. Ivannikova, L. S. Gorbunova, M. N. Trofimova, I. N. Azarova, K. Yu. Kokina, Alexey O. Bueverov, E. M. Kondratenko, E. N. Cherenkova, O. A. Kudrya, S. V. Koblov, I. M. Shilkina, I. N. Kovalev, M. Yu. Petrachenkova, Pavel O. Bogomolov, M. V. Matsievich, S. I. Kiyan, Natalia Voronkova, G. G. Chernyavskaya, Yu. Yu. Gumerova, O. S. Kuz'mina, V. D. Beznosenko, E. V. Fedosova, E. N. Kudryavtseva, G. V. Sadovskaya, N. A. Gorshilina, N. V. Kosheleva, V. A. Sinitsyna, M. L. Samsonyan
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 40, Pp 48-57 (2016)
Background: The beginning of a new era of direct acting antivirals sets up its own rules, that is, to achieve the highest efficacy with the shortest duration of treatment. It is assumed that the use of the first generation of direct acting antivirals